Related Experiment Video
Updated: Apr 11, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
RhoE is required for contact inhibition and negatively regulates tumor initiation and progression
Marta Hernández-Sánchez1,2, Enric Poch1, Rosa M Guasch3
1Universidad CEU-Cardenal Herrera, Facultad de Ciencias de la Salud, Dep. Ciencias Biomédicas, Moncada, Spain.
Abstract:
RhoE is a small GTPase involved in the regulation of actin cytoskeleton dynamics, cell cycle and apoptosis. The role of RhoE in cancer is currently controversial, with reports of both oncogenic and tumor-suppressive functions for RhoE. Using RhoE-deficient mice, we show here that the absence of RhoE blunts contact-inhibition of growth by inhibiting p27Kip1 nuclear translocation and cooperates in oncogenic transformation of mouse primary fibroblasts. Heterozygous RhoE+/gt mice are more susceptible to chemically induced skin tumors and RhoE knock-down results in increased metastatic potential of cancer cells. These results indicate that RhoE plays a role in suppressing tumor initiation and progression.
Insights
The small GTPase RhoE suppresses tumor initiation and progression by maintaining contact inhibition and inhibiting cell proliferation. Its absence increases susceptibility to skin tumors and cancer cell metastasis.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- RhoE, a small GTPase, influences actin dynamics, cell cycle, and apoptosis.
- The function of RhoE in cancer remains debated, with conflicting reports on its oncogenic or tumor-suppressive roles.
Purpose of the Study:
- To investigate the role of RhoE in tumor suppression.
- To elucidate the mechanisms by which RhoE may inhibit cancer initiation and progression.
Main Methods:
- Utilized RhoE-deficient mice models.
- Examined the effect of RhoE deficiency on contact inhibition and p27Kip1 nuclear translocation.
- Assessed susceptibility to chemically induced skin tumors.
- Investigated the impact of RhoE knockdown on cancer cell metastatic potential.
Main Results:
- Absence of RhoE impairs contact inhibition by preventing p27Kip1 nuclear translocation.
- RhoE deficiency cooperates with oncogenic transformation in mouse fibroblasts.
- RhoE+/gt mice exhibit increased susceptibility to skin tumors.
- RhoE knockdown enhances the metastatic potential of cancer cells.
Conclusions:
- RhoE acts as a tumor suppressor, inhibiting cancer initiation and progression.
- RhoE is crucial for maintaining normal cellular growth control and preventing metastasis.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
12:35Author Spotlight: Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos
Published on: April 14, 2023
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Mitogens and the Cell Cycle
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...